Citadel Advisors »

Elevation Oncology shares owned by Citadel Advisors

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.1M 1.6M 5.13
2023-12-31 $318k 592k 0.54
2023-09-30 $557k 840k 0.66
2023-06-30 $1.3M 839k 1.52
2021-12-31 $132k 22k 6.04

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Elevation Oncology

Farallon Capital Management
Point72 Asset Management
Tang Capital Management
Balyasny Asset Management
Aisling Capital Management
venBio Partners
Braidwell
Qiming U.S. Ventures Management
Darwin Global Management
BVF
Citadel Advisors
Vanguard Group
Artal Group
Hudson Bay Capital Management
Palo Alto Investors

View all funds holding Elevation Oncology